XNAS
JSPRW
Market cap18mUSD
Sep 24, Last price
0.00USD
Name
Jasper Therapeutics Inc
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Amplitude Healthcare Acquisition Corporation currently does not conduct extensive business operations. Its core strategy involves acquiring enterprises or their assets within the healthcare or related sectors. This will be accomplished via various corporate actions, including mergers, stock exchanges, share acquisitions, restructuring efforts, or similar business consolidations. The entity was established in 2019 and is headquartered in New York City.
Key people
Jeetinder Mahal
Chief Operating Officer · since 2023
Thomas Wiggans
Executive Chair of the Board · since 2026
Herb Cross
Chief Financial Officer, Corporate Secretary · since 2023
Judith Shizuru
Director · since 2021
Independent Director · since 2023
Vishal Kapoor
Independent Director · since 2023
Independent Director · since 2024
Christian Nolet
Independent Director · since 2021
Independent Director · since 2021
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||||
Revenues | |||||||
Cost of revenue | |||||||
Unusual Expense (Income) | |||||||
NOPBT | |||||||
NOPBT Margin | |||||||
Operating Taxes | |||||||
Tax Rate | |||||||
NOPAT | |||||||
Net income | |||||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | |||||||
BB yield | |||||||
| Debt | |||||||
Debt current | |||||||
Long-term debt | |||||||
Deferred revenue | |||||||
Other long-term liabilities | |||||||
Net debt | |||||||
| Cash flow | |||||||
Cash from operating activities | |||||||
CAPEX | |||||||
Cash from investing activities | |||||||
Cash from financing activities | |||||||
FCF | |||||||
| Balance | |||||||
Cash | |||||||
Long term investments | |||||||
Excess cash | |||||||
Stockholders' equity | |||||||
Invested Capital | |||||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | |||||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | |||||||
EV/EBITDA | |||||||
Interest | |||||||
Interest/NOPBT | |||||||